Bengaluru, India Innvolution, a group focused on interventional cardiology with a comprehensive portfolio of imaging and consumable products, announced today that it has raised growth capital from OrbiMed, a global healthcare focused investment firm. The funds will be used to ramp up the R&D efforts, develop
Today around 95% of Coronary Angioplasties require metal stents to enlarge a blocked artery. The stents may re-narrow leading to repeat stenting procedure or bypass surgery. Drug Coated Balloon is a new alternative that eliminates the stent usage & preserves the normal functions
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective At a time when coronary diseases are on the rise in India and globally, special drug-coated balloons are emerging as a
In a recent two day conference, Max Healthcare announced a milestone collaboration with Mayo Clinic, US, for implementation of global standards of cardiac care in India. Under the leadership of Dr Balbir Singh, Chairman Cardiology, Pan- Max Healthcare and Dr Gurpreet Sandhu, Vice Chair, Cardiology,
Quick access to medical images and reports in any Manipal Hospital network; images can be digitally transmitted as and when required globally Manipal Hospitals, one of India’s foremost healthcare providers, has entered into an agreement with FUJIFILM India, a pioneer in healthcare technology, to leverage
86-year-old female Patient, Sumitra Sharma, a resident of Gaya (Bihar) was a known Heart disease patient. Recently, she had a slipped in the washroom at her residence and suffered a fracture of left hip (neck of femur). She had a previous history of breast cancer
“Our key focus markets will be Tamil Nadu and Bengaluru in this cycle of growth”: Dr.Chandrakumar, Chairman Kauvery Hospitals, one of the leading hospital chains in South India, has built a strong foothold in its focus markets with over 2 decades of operations. Established in
Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), indicated for the management of type 2 diabetes has been developed in an oral formulation for the first time. Oral semaglutide will be a gamechanger for people with type 2 diabetes who prefer oral medications over injections. was
World Health Organization has recommended that all immune-compromised patients should get a third dose or booster shot of a vaccine against Covid-19. According to Subject Advisory Group of Experts (SAGE) of the UN health body, moderately and severely immunocompromised people should be offered an additional dose
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
